33.00
+0.50
+(1.54%)
At close: January 10 at 5:10:45 PM GMT+1
Key Executives
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eduardo Baviera Sabater | MD, CEO & Executive Director | 200k | -- | 1968 |
| Mr. Julio Baviera Sabater | President | 43.33k | -- | 1955 |
| Mr. Virgilio Leal Espí | Chief Financial Officer | -- | -- | -- |
| Mr. Antonio Peral Ortiz de la Torre | Company Secretary | -- | -- | -- |
Clínica Baviera, S.A.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 1,326
Description
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.
Corporate Governance
Clínica Baviera, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
Clínica Baviera, S.A. Earnings Date
Recent Events
July 16, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
QIA.DU Qiagen NV
43.80
-0.19%
NN6.F NanoRepro AG
1.4050
+1.81%
ESF0.MU Eurofins Scientific SE
49.22
0.00%
VOX.WA Voxel S.A.
128.50
+0.78%
ABMC American Bio Medica Corporation
0.0001
0.00%
IDHCl.XC
HTGMQ HTG Molecular Diagnostics, Inc.
0.0001
0.00%
MVF.AX Monash IVF Group Limited
1.2300
-0.81%
DAP.DE Danaher Corporation
230.80
-1.72%
PRM.L Proteome Sciences plc
4.8000
+40.35%